Search Results

You are looking at 1 - 2 of 2 items for :

  • "drug distribution" x
Clear All
Full access

Rowena N. Schwartz, Kirby J. Eng, Deborah A. Frieze, Tracy K. Gosselin, Niesha Griffith, Amy Hatfield Seung, Jennifer M. Hinkel, Philip E. Johnson, Shirley A. Johnson, Edward C. Li, Audrea Hotsko Szabatura and Michael K. Wong

regarding adherence to therapy, adverse events, toxicities, or side effects is not efficiently communicated across all relevant providers. For patients with cancer, the model for drug distribution and management of drug therapy often differs depending on

Full access

Timothy C. Zhu

their integrated system to determine these quantities before and after PDT treatment using motorized probes, they noted significant interprostatic and intraprostatic variations in the tissue optical properties and motexafin lutetium drug distribution